- Home
- SCPH vs NVCT Comparison
SCPH vs NVCT Comparison
Compare SCPH & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- NVCT
- Stock Information
- Founded
- SCPH 2013
- NVCT 2020
- Country
- SCPH United States
- NVCT United States
- Employees
- SCPH N/A
- NVCT N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- SCPH Health Care
- NVCT Health Care
- Exchange
- SCPH Nasdaq
- NVCT Nasdaq
- Market Cap
- SCPH 173.6M
- NVCT 184.9M
- IPO Year
- SCPH 2017
- NVCT 2022
- Fundamental
- Price
- SCPH $3.84
- NVCT $8.13
- Analyst Decision
- SCPH Strong Buy
- NVCT Strong Buy
- Analyst Count
- SCPH 3
- NVCT 3
- Target Price
- SCPH $14.00
- NVCT $17.00
- AVG Volume (30 Days)
- SCPH 289.6K
- NVCT 96.4K
- Earning Date
- SCPH 08-13-2025
- NVCT 08-05-2025
- Dividend Yield
- SCPH N/A
- NVCT N/A
- EPS Growth
- SCPH N/A
- NVCT N/A
- EPS
- SCPH N/A
- NVCT N/A
- Revenue
- SCPH $41,982,000.00
- NVCT N/A
- Revenue This Year
- SCPH $108.95
- NVCT N/A
- Revenue Next Year
- SCPH $73.83
- NVCT N/A
- P/E Ratio
- SCPH N/A
- NVCT N/A
- Revenue Growth
- SCPH 138.10
- NVCT N/A
- 52 Week Low
- SCPH $1.94
- NVCT $4.44
- 52 Week High
- SCPH $5.65
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- SCPH 56.83
- NVCT 37.24
- Support Level
- SCPH $3.86
- NVCT $8.79
- Resistance Level
- SCPH $4.17
- NVCT $9.30
- Average True Range (ATR)
- SCPH 0.23
- NVCT 0.50
- MACD
- SCPH -0.06
- NVCT -0.11
- Stochastic Oscillator
- SCPH 33.33
- NVCT 12.43
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.